Substandard and Falsified Medicines in Myanmar
<b>Background:</b> substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in Myanmar since then. The aim o...
Saved in:
Main Authors: | Mirai Sakuda (Author), Naoko Yoshida (Author), Takashi Takaoka (Author), Tomoko Sanada (Author), Mohammad Sofiqur Rahman (Author), Tsuyoshi Tanimoto (Author), Theingi Zin (Author), Kazuko Kimura (Author), Hirohito Tsuboi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discrimination of Falsified Erectile Dysfunction Medicines by Use of an Ultra-Compact Raman Scattering Spectrometer
by: Tomoko Sanada, et al.
Published: (2020) -
An Investigation into the Quality of Medicines in Yangon, Myanmar
by: Md. Rafiqul Islam, et al.
Published: (2018) -
Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites
by: Mohammad Sofiqur Rahman, et al.
Published: (2021) -
A Cross-Sectional Investigation for Verification of Globalization of Falsified Medicines in Cambodia, Indicated by Tablets of Sildenafil Citrate
by: Naoko Yoshida, et al.
Published: (2019) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019)